Thursday January 01, 1970

Registration and networking

Speakers

Getting the most out of your data

How are providers assessing and extracting value from their data? How do you best analyse it to improve outcomes and patient experience? And how do you best analyse it to optimise workflow and patient throughput? Three casestudies demonstrate what is possible and the pitfalls to avoid.

Speakers include:

Wolfgang Hofmann, Group head technology and innovation, Fresenius Group
Wolfgang will share how Fresenius is approaching digitalisation, implementing generative AI and moving to the cloud in the complexity of a large organisational structure.

Speakers

Wolfgang HofmannGroup Head of Technology and InnovationFresenius Group

The reawakening of nuclear medicine

Nuclear medicine long had its place in the diagnosis and treatment of disease, primarily in cardiology and oncology. Today, the nuclear medicine market is at an inflection point, as the rise of theragnostics and the advent of novel products is expected to nearly quadruple the size of the market in the next 10 years from ~$7bn to $25+bn by 2033. The enormous growth in the field is driven by continued radiopharmaceutical funding where 250+ trials are currently being conducted and by trial funding increasing ~45%+ p.a. between 2019 and 2022. This session features perspectives from a provider, radiopharmaceutical group and OEM on how this is accelerating growth, shaping the market and discussing the medium and long-term obstacles.

Moderation and market overview: Ian Poburenny, Director, Healthcare, Rothschild & Co

Speakers

Ian PoburennyDirector, HealthcareRothschild & Co